LYON, France, Nov. 7, 2007 (PRIME NEWSWIRE) -- EDAP TMS S.A. (NasdaqGM:EDAP - News), the global leader in High Intensity Focused Ultrasound for the treatment of prostate cancer, announced Ablatherm-HIFU achieved significant recognition at the annual World Congress of Endourology that concluded Saturday, November 3, in Cancun, Mexico. At the meeting, Ablatherm-HIFU was officially included within the ``Robotic Alternatives'' classification of localized prostate cancer treatments. This category includes robotic medical devices, basically represented by the widely known DaVinci robotic surgical device from Intuitive Surgical. The Ablatherm now joins the DaVinci as the sole HIFU technology in this classification.
